NO20010089L - Farmasöytisk levotyroksinpreparat - Google Patents

Farmasöytisk levotyroksinpreparat

Info

Publication number
NO20010089L
NO20010089L NO20010089A NO20010089A NO20010089L NO 20010089 L NO20010089 L NO 20010089L NO 20010089 A NO20010089 A NO 20010089A NO 20010089 A NO20010089 A NO 20010089A NO 20010089 L NO20010089 L NO 20010089L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical
pharmaceutical levothyroxine
levothyroxine preparation
excipients
Prior art date
Application number
NO20010089A
Other languages
English (en)
Other versions
NO20010089D0 (no
Inventor
Sven Alexander Schreder
Marion Nischwitz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20010089L publication Critical patent/NO20010089L/no
Publication of NO20010089D0 publication Critical patent/NO20010089D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen vedrører et farmasøytisk preparat som inneholder levotyroksinnatrium, kaliumjodid, mikrokrystallinsk cellulose og bindemidler, og som er fritt for antioksidanter eller andre hjelpestoffer, samt fremgangsmåte for fremstilling av preparatet.
NO20010089A 1998-07-07 2001-01-05 Farmasöytisk levotyroksinpreparat NO20010089D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830246A DE19830246A1 (de) 1998-07-07 1998-07-07 Pharmazeutische Zubereitung
PCT/EP1999/004485 WO2000002586A1 (de) 1998-07-07 1999-06-29 Pharmazeutische levothyroxinzubereitung

Publications (2)

Publication Number Publication Date
NO20010089L true NO20010089L (no) 2001-01-05
NO20010089D0 NO20010089D0 (no) 2001-01-05

Family

ID=7873182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010089A NO20010089D0 (no) 1998-07-07 2001-01-05 Farmasöytisk levotyroksinpreparat

Country Status (18)

Country Link
US (1) US6491946B1 (no)
EP (1) EP1094841B1 (no)
JP (1) JP2002520296A (no)
KR (1) KR20010071765A (no)
CN (1) CN1307486A (no)
AR (1) AR019899A1 (no)
AT (1) ATE273697T1 (no)
AU (1) AU751575B2 (no)
BR (1) BR9911884A (no)
CA (1) CA2336748A1 (no)
CZ (1) CZ296897B6 (no)
DE (2) DE19830246A1 (no)
HU (1) HUP0104985A3 (no)
ID (1) ID27150A (no)
NO (1) NO20010089D0 (no)
PL (1) PL344834A1 (no)
SK (1) SK20042000A3 (no)
WO (1) WO2000002586A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
JP2004525109A (ja) * 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US20030194436A1 (en) * 2001-08-10 2003-10-16 Franz Andrew G. Immediate release pharmaceutical compositions
US20030199585A1 (en) * 2001-08-10 2003-10-23 Franz G Andrew Levothyroxine compositions and methods
US20030195254A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US7192657B2 (en) * 2003-04-15 2007-03-20 3M Innovative Properties Company Ethynyl containing electron transport dyes and compositions
MX2007007860A (es) * 2004-12-27 2007-07-18 King Pharmaceuticals Res & Dev Envase impermeable al oxigeno con composiciones de la hormona tiroidea estabilizadas, secuestrante de oxigeno opcional, y metodos para el almacenamiento de composiciones farmaceuticas de la hormona tiroidea.
US7858663B1 (en) 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
US20150017236A1 (en) * 2013-07-09 2015-01-15 Jefferson J. Gregory Pharmaceutical compositions of thyroid hormone
US20200046664A1 (en) 2016-10-10 2020-02-13 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
DE102017122807B4 (de) 2017-09-29 2023-02-09 Berlin-Chemie Ag Orales Schilddrüsentherapeutikum
DK3576795T3 (da) 2017-02-03 2021-06-07 Berlin Chemie Ag Oralt skjoldbruskkirtelterapeutikum
KR20240039868A (ko) * 2022-09-20 2024-03-27 한국유나이티드제약 주식회사 갑상선 보호용 약학조성물 및 이의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US5635209A (en) * 1995-10-31 1997-06-03 Vintage Pharmaceuticals, Inc. Stabilized composition of levothyroxine sodium medication and method for its production
BR9611306A (pt) 1995-11-14 1999-12-28 Knoll Pharmaceuticals Co Preparação farmacêutica e, composto farmacêutica estável.
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine

Also Published As

Publication number Publication date
AU751575B2 (en) 2002-08-22
EP1094841B1 (de) 2004-08-18
SK20042000A3 (sk) 2001-09-11
US6491946B1 (en) 2002-12-10
CN1307486A (zh) 2001-08-08
CZ296897B6 (cs) 2006-07-12
ATE273697T1 (de) 2004-09-15
JP2002520296A (ja) 2002-07-09
DE59910298D1 (de) 2004-09-23
CA2336748A1 (en) 2000-01-20
BR9911884A (pt) 2001-03-27
ID27150A (id) 2001-03-08
HUP0104985A3 (en) 2003-03-28
AU4779399A (en) 2000-02-01
CZ200174A3 (en) 2001-05-16
KR20010071765A (ko) 2001-07-31
DE19830246A1 (de) 2000-01-13
EP1094841A1 (de) 2001-05-02
HUP0104985A2 (hu) 2002-04-29
NO20010089D0 (no) 2001-01-05
WO2000002586A1 (de) 2000-01-20
PL344834A1 (en) 2001-11-19
AR019899A1 (es) 2002-03-20

Similar Documents

Publication Publication Date Title
NO20010089L (no) Farmasöytisk levotyroksinpreparat
ES2165833T1 (es) Composicion farmaceutica revestida enterica y procedimiento de fabricacion.
HUP9802086A2 (hu) Piperidino-alkanol vegyületeket tartalmazó gyógyszerkészítmények
NO941358L (no) Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
MX9705383A (es) Compuesto que tienen efectos sobre los sistemas relacionados con la serotonina.
NO20051427L (no) Fremgangsmate for produksjon av hydroksyalkyl stivelsesderivater
YU56995A (sh) Soli derivata indola
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
NO20081631L (no) Lav hygroskopisk Aripiprazol medikament forbindelse og fremgangsmate for fremstilling derav
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
NO962187D0 (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
NO20060208L (no) Farmasoytisk preparat
NO20014101L (no) Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte
AR003476A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
DE69513254T2 (de) Gepirone enthaltende Zusammensetzungen
TR200000148T2 (tr) 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler.
NO20005758D0 (no) Farmasöytisk preparat som inneholder levotyroksin-natrium
SE8901003D0 (sv) Snabbloesliga preparat
NO992999L (no) Farmasöytisk blanding for oral administrering
JPS5315411A (en) Improvent concerning to organic compound
PT984922E (pt) Preparacao de composto de tri-iodo benzeno

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application